| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/29/2002 | WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 08/29/2002 | WO2002003988A3 Use of substituted indole compounds for treating neuropeptide y-related conditions |
| 08/29/2002 | WO2002002506A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2001097805A3 Solid valsartan pharmaceutical compositions |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001091745A3 Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions |
| 08/29/2002 | WO2001085093A3 Compounds and methods for modulating cerebral amyloid angiopathy |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001081336A8 Process for the synthesis of a known tetrazol derivative |
| 08/29/2002 | WO2001079284A3 Therapeutic compounds and methods for formulating v3, a versican isoform |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001060408A3 Microcompetiton and human disease |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | WO2000068188A9 Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY |
| 08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |
| 08/29/2002 | WO2000064443A9 Synergistic effects of amlodipine and atorvastatin |
| 08/29/2002 | WO2000061606A9 Novel human voltage-gated potassium channel |
| 08/29/2002 | WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 08/29/2002 | WO2000037502A9 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/29/2002 | WO2000034474A9 Growth factor homolog zvegf3 |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120147 Micronized torsemide |
| 08/29/2002 | US20020120145 Inhibiting farnesyl protein transferase. |
| 08/29/2002 | US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 08/29/2002 | US20020120123 Human vascular endothelial growth factor 2 |
| 08/29/2002 | US20020120103 17 human secreted proteins |
| 08/29/2002 | US20020120102 Native Arg-Gly-Asp (RGD) motif has been deleted or has been replaced by an amino acid sequence having no integrin- binding activity, or an integrin-binding amino acid sequence other than RGD which contains aspartic acid or glutamic acid |
| 08/29/2002 | US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents |
| 08/29/2002 | US20020120013 Regulation of phospholipase D activity |
| 08/29/2002 | US20020120006 Administering benzyl, naphthyl acid derivatives |
| 08/29/2002 | US20020119999 Imidazole dione or one, thione derivatives as antitumor and antiinflammatory agents, also treats cardiovascular disease, nephropathies and retinopathies |
| 08/29/2002 | US20020119992 Anticoagulants |
| 08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
| 08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 08/29/2002 | US20020119976 Tetracyclic derivatives, process of preparation and use |
| 08/29/2002 | US20020119975 Autoimmune disease; antiinflammatory agents; antiallergens; antiproliferative agents; anticancer agents |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
| 08/29/2002 | US20020119965 Nitriloxy derivatives of (R) and (S)-carnitine |
| 08/29/2002 | US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
| 08/29/2002 | US20020119961 Bridged piperazine derivatives |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | US20020119946 Formative agent of protein complex |
| 08/29/2002 | US20020119932 RGD-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | US20020119931 Peptide inhibiting platelet derived growth factor (PDGF-BB) and fibroblast growth factor (bFGF) activity |
| 08/29/2002 | US20020119554 Arginase II |
| 08/29/2002 | US20020119548 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/29/2002 | US20020119479 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant GPIIIa and/or variant GPIIb allele |
| 08/29/2002 | US20020119202 For therapy of cancer and other angiogenic-dependent diseases |
| 08/29/2002 | US20020119191 Pharmaceutical or food composition for treatment or prevention of brain edema |
| 08/29/2002 | US20020119186 Establishing a drug depot in tissues under the user's skin surface by applying a transdermal drug delivery system on a user's skin; allowing transdermal drug delivery system to be applied on skin area without heating; placing heating source |
| 08/29/2002 | US20020119164 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119148 ErbB4 antagonists |
| 08/29/2002 | US20020119144 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 08/29/2002 | US20020119143 Antithrombin III for disorders caused by angiogenesis |
| 08/29/2002 | DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 08/29/2002 | DE10106970A1 Neues Benzoylguanidinsalz New Benzoylguanidinsalz |
| 08/29/2002 | CA2737095A1 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 08/29/2002 | CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy |
| 08/29/2002 | CA2451089A1 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 08/29/2002 | CA2442742A1 Quinazoline derivatives |
| 08/29/2002 | CA2439898A1 Compounds co-inducing cholinergic up-regulation and inflammation down-regulation and uses thereof |
| 08/29/2002 | CA2439193A1 Casoase 3 inhibitors |
| 08/29/2002 | CA2438711A1 Tryptase inhibitors |
| 08/29/2002 | CA2438685A1 Tryptase inhibitors |
| 08/29/2002 | CA2438682A1 Antibodies that bind both bcma and taci |
| 08/29/2002 | CA2438519A1 Emulsions and aqueous dispersions of phytosterols |
| 08/29/2002 | CA2438369A1 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | CA2438312A1 Anthrone derivatives and their use as jnk inhibitors |
| 08/29/2002 | CA2438235A1 Neurotransmission-associated proteins |
| 08/29/2002 | CA2437977A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 08/29/2002 | CA2437529A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | CA2434652A1 Type 2 cytokine receptor and nucleic acids encoding same |
| 08/29/2002 | CA2433841A1 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof |
| 08/29/2002 | CA2433348A1 Detection of compounds that modulate inflammatory responses |
| 08/29/2002 | CA2432932A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | CA2432208A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | CA2426811A1 Novel formulations of carvedilol |
| 08/28/2002 | WO2001064242A1 Drugs for ameliorating retinal function |
| 08/28/2002 | EP1234834A1 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234821A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 08/28/2002 | EP1234816A1 Scyphostatin analogues as SMase inhibitors |
| 08/28/2002 | EP1234815A2 Crystalline choline ascorbate |
| 08/28/2002 | EP1234581A1 Wound contraction inhibitors |
| 08/28/2002 | EP1234188A2 Protein kinase regulation |
| 08/28/2002 | EP1234185A2 Pin1 as a marker for abnormal cell growth |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1234025A1 Human enzymes of the metalloprotease family |
| 08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233981A1 G-protein coupled receptor |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233973A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 08/28/2002 | EP1233965A1 Isoquinoline and quinazoline derivatives for the treatment of cns disorders |
| 08/28/2002 | EP1233963A2 Novel sulfonyl oxazole amines |
| 08/28/2002 | EP1233962A2 Novel heterocyclic compounds and their use as medicines |
| 08/28/2002 | EP1233960A2 Polymorphic salt of an anti-migraine drug |